This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

C. James Klett, PhD; Perry Point, Md; Eugene Caffey, Jr., MD

Arch Gen Psychiatry. 1972;26(4):374-379.

Abstract
Chronic schizophrenic males receiving both antipsychotic and antiparkinson medication had the latter replaced by placebo for a sixweek study period. To provide a double-blind control, a smaller group received matching tablets of benztropine mesylate. Of 403 patients receiving placebos, 7% were withdrawn from the study because of substantial return or appearance of extrapyramidal symptoms. Another 11% were judged to be worse from the rating scale data, but the remaining 82% seemed to get along quite well without antiparkinson medication, experiencing at most some temporary symptoms of extrapyramidal system disturbance. From these and other data, it is recommended that clinicians reconsider their prescribing habits, particularly prophylactic and long-term use of antiparkinson drugs.

Author Affiliations
Washington, DC

From the Central Neuropsychiatric Research Laboratory, Veterans Administration Hospital, Perry Point, Md, (Dr. Klett) and the Veterans Administration Central Office, Washington, DC (Dr. Caffey).

Footnotes
Accepted for publication July 6, 1971.

Reprint requests to Central NP Research Laboratory, Veterans Administration Hospital, Perry Point, Md 21902 (Dr. Klett).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Carbamazepine and Thyroid Function in Affectively Ill Patients: Clinical and Theoretical Implications
Roy-Byrne et al.
Arch Gen Psychiatry 1984;41:1150-1153.
ABSTRACT  

Initial Anticholinergic Prophylaxis for Neuroleptic-Induced Extrapyramidal Syndromes
Keepers et al.
Arch Gen Psychiatry 1983;40:1113-1117.
ABSTRACT  

Serum Levels of Anticholinergic Drugs in Treatment of Acute Extrapyramidal Side Effects
Tune and Coyle
Arch Gen Psychiatry 1980;37:293-297.
ABSTRACT  

Hospital Surveys of Prescribing Practices With Psychotherapeutic Drugs: A Critical Examination
Prien et al.
Arch Gen Psychiatry 1978;35:1271-1275.
ABSTRACT  

Are Prophylactic Antiparkinson Drugs Necessary? A Controlled Study of Procyclidine Withdrawal
Rifkin et al.
Arch Gen Psychiatry 1978;35:483-489.
ABSTRACT  

Dopamine Excretion and Vulnerability to Drug-Induced Parkinsonism: Schizophrenic Patients
Crowley et al.
Arch Gen Psychiatry 1978;35:97-104.
ABSTRACT  

Hyperpyrexia From Drug Combinations
Westlake and Rastegar
JAMA 1973;225:1250-1250.
ABSTRACT  

Drug Spotlight Program: Uses of Psychotherapeutic Drugs
HOLLISTER
ANN INTERN MED 1973;79:88-98.
ABSTRACT